Advancements in immunosuppression therapies have transformed the landscape of heart transplantation and significantly improved outcomes for transplant recipients. Modern immunosuppression strategy hinges on deploying a combination of immunosuppressive agents; this chapter will cover the different categories of maintenance immunosuppressive agents used in heart transplant patients, their clinical utility, and strategies involving different combinations of these agents to adjust to various clinical phenotypes.